Mon panier

IL-11

IL-11 Informations sur la molécule

Nom anglaisInterleukin-11Nombre de médicaments commercialisés1
Nombre de médicaments cliniques4Alias de la cibleOprelvekin,IL-11,Interleukin 11,Adipogenesis inhibitory factor,AGIF
Phase de R&D la plus avancéeApproved
Nom anglaisInterleukin-11
Alias de la cibleOprelvekin,IL-11,Interleukin 11,Adipogenesis inhibitory factor,AGIF
Nombre de médicaments commercialisés1
Nombre de médicaments cliniques4
Phase de R&D la plus avancéeApproved

IL-11 Liste de produits

  • Attribut

    Protein (11)Kits (2)

  • Bibliothèque de produits

    En ligne (13)

  • Espèces

    Human (6)Cynomolgus (3)Mouse (3)Canine (1)

  • Étiquette

    His Tag (5)His Tag & Avi Tag (4)Fc Tag (2)- (2)

  • Marqueur

    Unconjugated (7)Biotin-labeled (4)- (2)

IL-11Contexte de la molécule

Interleukin-11 (IL-11) is a pleiotropic cytokine that stimulates megakaryocytopoiesis, resulting in increased production of platelets, as well as activating osteoclasts, inhibiting epithelial cell proliferation and apoptosis, and inhibiting macrophage mediator production. These functions may be particularly important in mediating the hematopoietic, osseous and mucosal protective effects of IL-11. The cytokine also possesses anti-inflammatory activity, and has been proposed as a therapeutic agent in the treatment of chronic inflammatory diseases, such as Crohn's disease and rheumatoid arthritis. Although IL-11 was initially believed to be restricted to mammals, subsequent studies demonstrated it to be expressed in fish. Despite close similarity in gene structure and conservation of key amino acids between fish and mammalian IL-11, they share relatively low overall amino acid identity and may not necessarily be functionally analogous.

IL-11Alias de la molécule

IL-11,Interleukin-11,AGIF,Oprelvekin,IL11

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
9MW38119MW3811Phase 2 ClinicalMabwell (Shanghai) Bioscience Co LtdCicatrix; Fibrosis; Idiopathic Pulmonary Fibrosis; Neoplasms; Pulmonary Fibrosis; Solid tumours
Details
BI-765423BI-765423; BI765423Phase 2 ClinicalBoehringer Ingelheim LtdIdiopathic Pulmonary Fibrosis
Details
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co LtdAsthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive
Details
LASN-03Lassen Therapeutics
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )ApprovedHangzhou Jiuyuan Gene Biomedical Co LtdThrombocytopenia
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments commercialisés
  • Informations sur les médicaments cliniques